The study is to evaluate the chronic-dose efficacy and the safety of Albuterol MDPI compared
to placebo in pediatric participants with asthma.
Minimum age: 4 Years.
Maximum age: 11 Years.
Gender(s): Both.
Teva Investigational Site 12496, Birmingham, Alabama, United States
Teva Investigational Site 12500, Mobile, Alabama, United States
Teva Investigational Site 12481, Little Rock, Alaska, United States
Teva Investigational Site 12515, Anaheim, California, United States
Teva Investigational Site 12505, Costa Mesa, California, United States
Teva Investigational Site 12476, Huntington Beach, California, United States
Teva Investigational Site 12519, Los Angeles, California, United States
Teva Investigational Site 12484, Mission Viejo, California, United States
Teva Investigational Site 12510, Riverside, California, United States
Teva Investigational Site 12483, Rolling Hills Estates, California, United States
Teva Investigational Site 12511, Sacramento, California, United States
Teva Investigational Site 12485, Stockton, California, United States
Teva Investigational Site 12512, Centennial, Colorado, United States
Teva Investigational Site 12522, Gainesville, Florida, United States
Teva Investigational Site 12535, Hollywood, Florida, United States
Teva Investigational Site 12526, Miami, Florida, United States
Teva Investigational Site 12516, Orlando, Florida, United States
Teva Investigational Site 12517, Tamarac, Florida, United States
Teva Investigational Site 12527, Vero Beach, Florida, United States
Teva Investigational Site 12513, Winter Park, Florida, United States
Teva Investigational Site 12486, Gainesville, Georgia, United States
Teva Investigational Site 12497, Lawrenceville, Georgia, United States
Teva Investigational Site 12480, Savannah, Georgia, United States
Teva Investigational Site 12508, Shiloh, Illinois, United States
Teva Investigational Site 12518, Iowa City, Iowa, United States
Teva Investigational Site 12523, Covington, Louisiana, United States
Teva Investigational Site 12495, Warrensberg, Missouri, United States
Teva Investigational Site 12533, Papillion, NE, Thailand
Teva Investigational Site 12509, Northfield, New Jersey, United States
Teva Investigational Site 12524, Brooklyn, New York, United States
Teva Investigational Site 12473, Raleigh, North Carolina, United States
Teva Investigational Site 12477, Cincinnati, Ohio, United States
Teva Investigational Site 12525, Cleveland, Ohio, United States
Teva Investigational Site 12502, Middleburg Heights, Ohio, United States
Teva Investigational Site 12478, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12487, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12506, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12492, Tulsa, Oklahoma, United States
Teva Investigational Site 12507, Gresham, Oregon, United States
Teva Investigational Site 12501, Normal, Pennsylvania, United States
Teva Investigational Site 12493, Pittsburgh, Pennsylvania, United States
Teva Investigational Site 12488, Upland, Pennsylvania, United States
Teva Investigational Site 12514, Greenville, South Carolina, United States
Teva Investigational Site 12474, Orangeburg, South Carolina, United States
Teva Investigational Site 12479, Spartanburg, South Carolina, United States
Teva Investigational Site 12489, Boerne, Texas, United States
Teva Investigational Site 12475, Waco, Texas, United States
Teva Investigational Site 12491, Burke, Virginia, United States
Teva Investigational Site 12504, Charlottesville, Virginia, United States
Teva Investigational Site 12482, Richmond, Virginia, United States
Teva Investigational Site 12498, Richmond, Virginia, United States
Teva Investigational Site 12490, Spokane, Washington, United States